Tag: GeneDX

Buccal Swab Added as WGS Sample Collection Option

GeneDx announced the availability of its GenomeXpress and GenomeSeqDx whole genome sequencing (WGS) tests with buccal swabs as an alternative sample collection option for biological parents or other immediate family members. Sequencing biological parent genomes alongside patient genomes—known as trio analysis—aids in disease diagnosis and greatly increases diagnostic yield rates. “We…

Continue Reading Buccal Swab Added as WGS Sample Collection Option

Pharmacogenomics Market Is Booming Worldwide 2023-2030

  “Coherent Market Insights offers a 25% discount on Pharmacogenomics Market Reports on Single User Access and Unlimited User Access” Pharmacogenomics Market Size Projections : Global pharmacogenomics market is estimated to be valued at US$ 14,028.01 million in 2022 and is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). Pharmacogenomics, often known as pharmacogenetics, is a branch…

Continue Reading Pharmacogenomics Market Is Booming Worldwide 2023-2030

Neurogenetic Testing Market Worth Observing Growth | GeneDx, Illumina, Labcorp

Global Neurogenetic Testing Market Growth (Status and Outlook) 2023-2029 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of…

Continue Reading Neurogenetic Testing Market Worth Observing Growth | GeneDx, Illumina, Labcorp

Increase in Fetal Chromosomal Abnormalities Drives Growth

DUBLIN, May 24, 2023 /PRNewswire/ — The “Carrier Screening Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global carrier screening market is expected to grow from $2.03 billion in…

Continue Reading Increase in Fetal Chromosomal Abnormalities Drives Growth

GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate

NEW YORK – GeneDx said Tuesday after market close that its first quarter revenues fell 20 percent to $43.1 million from $53.9 million a year ago but easily outstripped the Wall Street consensus estimate of $38.0 million. Almost all revenues in the three months ended March 31 came from diagnostic testing….

Continue Reading GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate

New Products Posted to GenomeWeb: Roche, GeneDx

Roche Kapa HyperExome V2 Probes Roche has launched its Kapa HyperExome V2 Probes, a whole-exome sequencing panel that provides a key update to the company’s Kapa HyperCap Target Enrichment portfolio. The new panel covers recent versions of the ACMGv3.1, RefSeq, CCDS, ClinVar, Ensembl, and COSMIC genomic databases within a compact…

Continue Reading New Products Posted to GenomeWeb: Roche, GeneDx

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing…

Continue Reading GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

2023-05-04 | NDAQ:WGS | Press Release

New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing…

Continue Reading 2023-05-04 | NDAQ:WGS | Press Release

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome

STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing tests with buccal swabs as an alternative sample collection option for biological parents or other…

Continue Reading GeneDx Adds Buccal Swab as Non-Invasive Whole Genome

Carrier Screening Global Market Report 2023

New York, April 26, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Carrier Screening Global Market Report 2023” – www.reportlinker.com/p06450944/?utm_source=GNW , Myriad Genetics Inc., Eurofins Scientific SE, OPKO Health Inc., Quest Diagnostics Inc., Luminex Corporation, BGI Genomics, Gene by Gene, OME Care, MedGenome Inc., and Otogenetics Corporation….

Continue Reading Carrier Screening Global Market Report 2023

Whole Exome Sequencing Market Trends, Share, Industry Size, Growth, Demand, Opportunities and Forecast By 2029

PRESS RELEASE Published April 25, 2023 Recent study report released by Data Bridge Market research titled “Global Whole Exome Sequencing Market” (covering USA, Europe, China, Japan, India, South East Asia, etc) highlights opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. This research report presents key insights on…

Continue Reading Whole Exome Sequencing Market Trends, Share, Industry Size, Growth, Demand, Opportunities and Forecast By 2029

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

NEW YORK – As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation service in partnership with genome analysis company Fabric Genomics. Priced at $1,000 per sample, the new…

Continue Reading Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

Validea Kenneth Fisher Strategy Daily Upgrade Report – 3/10/2023

The following are today’s upgrades for Validea’s Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins. HARMONY GOLD MINING CO. (ADR) (HMY) is a small-cap value stock in…

Continue Reading Validea Kenneth Fisher Strategy Daily Upgrade Report – 3/10/2023

Diagnosing Ehlers-Danlos Syndrome (EDS): DNA Testing Guide

A Guide to Ehlers-Danlose Syndrome and DNA Testing This guide offers an in-depth look at how DNA testing can help diagnose Ehlers-Danlos Syndrome (EDS), a rare genetic disorder that affects the body’s connective tissue. The article outlines four key steps to follow when using DNA testing to diagnose EDS, including choosing…

Continue Reading Diagnosing Ehlers-Danlos Syndrome (EDS): DNA Testing Guide

North America Whole Exome Sequencing Market to Grow at an Impressive CAGR of 22.0% by 2029

PRESS RELEASE Published February 15, 2023 Data Bridge Market research has recently released expansive research titled “North America Whole Exome Sequencing Market” guarantees you will remain better informed than your competition. This study provides the broader perspective of the market place with its comprehensive market insights and analysis which eases…

Continue Reading North America Whole Exome Sequencing Market to Grow at an Impressive CAGR of 22.0% by 2029

Gene Panel Market 2023-2028 Remarkably Focusing on Top Market Drivers and Opportunities, Advanced Technologies

Key players are Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd. Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced…

Continue Reading Gene Panel Market 2023-2028 Remarkably Focusing on Top Market Drivers and Opportunities, Advanced Technologies

AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

HOLLYWOOD, Florida – Illumina provided the first explanation for how its new Complete Long Reads (CLR) product will work as well as some customer data and testimonials at a Wednesday workshop here at the Advances in Genome Biology and Technology annual meeting. First, DNA molecules are tagmented to generate long…

Continue Reading AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

VCV000038126.28 Observations – ClinVar – NCBI

1 SCV000301220.2 Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Pathogenic reviewed by expert panel curation Breast-ovarian cancer, familial, susceptibility to, 2 (unknown ) germline Variant allele predicted to encode a truncated non-functional protein. 1 SCV000785901.2 Counsyl Pathogenic criteria provided,single submitter clinical testing Breast-ovarian cancer, familial, susceptibility to,…

Continue Reading VCV000038126.28 Observations – ClinVar – NCBI

VCV000698353.6 – ClinVar – NCBI

Likely benign (Nov 17, 2018) criteria provided, single submitter Method: clinical testing Arrhythmia Affected status: unknown Allele origin: germline Color Health, Inc Accession: SCV001358509.1 Submitted: (May 19, 2020) Likely benign (Apr 19, 2020) criteria provided, single submitter Method: clinical testing Long QT syndrome Affected status: unknown Allele origin: germline Invitae…

Continue Reading VCV000698353.6 – ClinVar – NCBI

VCV000445854.7 Observations – ClinVar – NCBI

1 SCV000610624.1 Center for Pediatric Genomic Medicine,Children’s Mercy Hospital and Clinics Benign criteria provided,single submitter clinical testing not provided (not provided ) germline 1 SCV000700353.2 Eurofins NTD, LLC Uncertain significance criteria provided,single submitter clinical testing 1 not provided (unknown ) germline 1 Single Heterozygote www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CYP21A2 mixed 1 SCV001137083.1 Mendelics Benign…

Continue Reading VCV000445854.7 Observations – ClinVar – NCBI

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset the largest of its kind…

Continue Reading GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GeneDx Announces the Sequencin – GuruFocus.com

GAITHERSBURG, Md., Sept. 21, 2021 GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset…

Continue Reading GeneDx Announces the Sequencin – GuruFocus.com

Expanding the diagnosis for Xia-Gibbs Syndrome

Xia-Gibbs Syndrome (XGS) is a rare genetic disorder that results in severe developmental delay, sleep apnea, delayed speech and upper body weakness. Image courtesy of the National Human Genome Research Institute In 2014, a team led by Dr. Richard Gibbs, director of the Human Genome Sequencing Center and Wofford Cain Chair and…

Continue Reading Expanding the diagnosis for Xia-Gibbs Syndrome

GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States

GeneDx is a rapidly growing CAP and CLIA certified diagnostic genetic testing laboratory for molecular genetics. Our historic mission has been to make clinical diagnostic testing available for people with genetic conditions and their families. We apply cutting edge technologies that provide a wide array of molecular genetic diagnostic tests,…

Continue Reading GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States